Predict your next investment

Asgard company logo
HEALTHCARE | Biotechnology
asgardthx.com

See what CB Insights has to offer

Founded Year

2018

Stage

Seed VC | Alive

Total Raised

$7M

Last Raised

$7M | 2 mos ago

About Asgard

Asgard is a biotechnology company that develops cancer therapy platform for reprogramming tumor cells for patients.

Asgard Headquarter Location

Nordanvag 3G 1506

Lund, 221 84,

Sweden

+46 (0) 73 156 60 72

Latest Asgard News

08:00 ET ASGARD backed Angstrom Technology acquires Connect 2 Cleanrooms Ltd.

Jan 18, 2022

. Transformational acquisition adds substantial scale, geographic reach, and additional vertically integrated capabilities, to better serve clients on both sides of the Atlantic News provided by Share this article Share this article NEW YORK, Jan. 18, 2022 /PRNewswire/ -- ASGARD Partners & Co. ("ASGARD"), a New York based private equity firm, announced today that its portfolio company, Angstrom Technology ("Angstrom" or the "Company"), an industry leader in cleanroom design and production, has acquired Connect 2 Cleanrooms Limited ("C2C"). The acquisition will expand the Company's geographic coverage outside of North America and bolster its capabilities and service offering. Connect 2 Cleanrooms Ltd. Established in 2002, C2C operates internationally from its head office in Lancaster, UK, with additional offices in London and Utrecht in the Netherlands. C2C is a trusted provider of highly engineered and mission critical cleanrooms for Healthcare, Pharma, and Industrial clients. C2C's vertically integrated and comprehensive offering spans engineering, design & build, and testing & validation services. Additionally, C2C offers cleanroom consumables and supplies through its fully integrated e-commerce platform www.cleanroomshop.com . Joe Govier, Founder and CEO of Connect 2 Cleanrooms, will continue to lead the UK-based business alongside the existing management team. For more information, please visit www.connect2cleanrooms.com . Karan Rai, Managing Partner of ASGARD, said, "The C2C acquisition adds a strong European presence to the already robust North American presence for Angstrom. The acquisition also gives Angstrom a deeper penetration into some of the world's fastest growing end markets such as Pharma, Biotech, and Cell & Gene Therapy. This transaction is just the beginning of a long-term growth strategy focused on consolidating the cleanroom and controlled environment industry. We think the two companies are a great strategic and cultural fit and are excited to welcome the highly talented C2C team into the Angstrom family." "This acquisition will accelerate our international expansion and bring our existing and future customers a much higher degree of expertise and service from a larger and more capable platform," said Matt Isard, CEO of Angstrom. "We are focused on building the most competent and customer-focused company in the industry and this is an important step in that direction. I am excited to welcome Joe Govier and the rest of the C2C team to Angstrom and look forward to integrating best practices from C2C into Angstrom and vice-versa." Robert Beall, Partner of ASGARD, said "Connect 2 Cleanrooms is a recognized leader in the rapidly growing critical environment industry across the UK and Europe and an ideal complement to the Angstrom business. Now with a global platform, we believe the Company is strongly positioned for continued growth as organizations in a variety of sectors seek to protect critical processes and meet regulatory or compliance objectives. We look forward to partnering with the Angstrom/C2C leadership team as it continues to broaden its customer base, pursue strategic acquisitions, and enhance its service offerings and capabilities." Joe Govier, added, "It was important for us to join forces with a company that holds the same values, integrity, and vision for our business and employees. We are confident that this transaction will enable Angstrom and C2C to build upon the strong technical foundation that exists today and fulfill a joint-mission of creating a global controlled environment solutions platform, and we are excited for the future of the group and teams within." Terms of the transaction were not disclosed. Plante & Moran PLLC and BDO acted as buyside advisors to ASGARD. McGuireWoods London LLP and Chapman and Cutler LLP served as counsel to ASGARD. About Angstrom Technology Headquartered in Grand Rapids, Michigan, Angstrom Technology is a market leader in cleanroom production across the U.S., Canada, and Mexico. Since 1989, Angstrom has provided cleanroom build, design, and maintenance services to some of the most respected companies in the world. Angstrom's passion is to provide its customers with the most effective and efficient designs, superior quality, and outstanding service. For more information, please visit  www.angstromtechnology.com . About ASGARD Partners & Co. ASGARD Partners & Co. is a private equity firm focused on investing in leading manufacturing, distribution, and services businesses in partnership with proven management teams. ASGARD seeks investment opportunities in businesses with defensible value propositions and strong growth prospects that can also benefit from the support of its investing and operating experience, access to capital, and strategic guidance. Sectors of particular focus include defense, government services, aerospace, industrial or business services, and specialty manufacturing. For more information, please visit  https://asgardpartners.com . SOURCE ASGARD Partners & Co.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.